1. Zhang X, Dong P, Xu L, Tian Y, Sun H, Shi H, Duan Z, Chen L, Ren F. The different expression of caspase-1 in HBV-related liver disease and acts as a biomarker for acute-on-chronic liver failure. BMC Gastroenterol. 2019 Aug 20;19(1):148. doi: 10.1186/s12876-019-1064-3. PMID: 31429707; PMCID: PMC6700995.

2. Wang H, Chen L, Zhang X, Xu L, Xie B, Shi H, Duan Z, Zhang H, Ren F. Kaempferol protects mice from d-GalN/LPS-induced acute liver failure by regulating the ER stress-Grp78-CHOP signaling pathway. Biomed Pharmacother. 2019 Mar;111:468-475. doi: 10.1016/j.biopha.2018.12.105. Epub 2018 Dec 27. PMID: 30594786.

3. Chuai X, Xie B, Deng Y, Zhao Y, Wang W, Gao Z, Wang W, Qiu X, Tan W. HBV antigen and DNA loss from mouse serum is associated with novel vaccine-induced HBV surface antigen-specific cell-mediated immunity and cytokine production. Antiviral Res. 2019 Jan;161:20-27. doi: 10.1016/j.antiviral.2018.11.002. Epub 2018 Nov 10. PMID: 30423362.

4. Chao D, Pang L, Shi Y, Wang W, Liu K. AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loop. Biochem Biophys Res Commun. 2019 Feb 5;509(2):535-540. doi: 10.1016/j.bbrc.2018.12.102. Epub 2018 Dec 28. PMID: 30598263.

5. Ji J, Zhou X, Xu P, Li Y, Shi H, Chen D, Li R, Shi H. Deficiency of apoptosis-stimulating protein two of p53 ameliorates acute kidney injury induced by ischemia reperfusion in mice through upregulation of autophagy. J Cell Mol Med. 2019 Apr;23(4):2457-2467. doi: 10.1111/jcmm.14094. Epub 2019 Jan 23. PMID: 30675758; PMCID: PMC6433670.

6. Yang T, Gao Y, Liu D, Wang Y, Wu J, Liu X, Shi Y, Chen D. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma. Biochem Biophys Res Commun. 2019 Jan 15;508(3):769-774. doi: 10.1016/j.bbrc.2018.11.181. Epub 2018 Dec 6. PMID: 30528232.

7. Wang W, Niu S, Qiao L, Wei F, Yin J, Wang S, Ouyang Y, Chen D. Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis. Biomed Res Int. 2019 Feb 11;2019:8727935. doi: 10.1155/2019/8727935. Erratum in: Biomed Res Int. 2021 Dec 22;2021:9808613. doi: 10.1155/2021/9808613. PMID: 30886864; PMCID: PMC6388510.

8. Xu J, Zang Y, Liu D, Yang T, Wang J, Wang Y, Liu X, Chen D. DRAM is Involved in Hypoxia/Ischemia-Induced Autophagic Apoptosis in Hepatocytes. Aging Dis. 2019 Feb 1;10(1):82-93. doi: 10.14336/AD.2018.0210. PMID: 30705770; PMCID: PMC6345327.

9. Xie F, Dong J, Zhu Y, Wang K, Liu X, Chen D, Meng Q. HIF1a Inhibitor Rescues Acute-on-Chronic Liver Failure. Ann Hepatol. 2019 Sep-Oct;18(5):757-764. doi: 10.1016/j.aohep.2019.03.007. Epub 2019 Jul 22. PMID: 31402229.

10. Dong J, Xie F, Jia L, Li J, Hu Z, Zhu Y, Yu H, Zhao Y, Yao Q, Meng Q. Clinical characteristics of liver failure with hemophagocytic lymphohistiocytosis. Sci Rep. 2019 May 31;9(1):8125. doi: 10.1038/s41598-019-43909-w. PMID: 31148551; PMCID: PMC6544643.

11. Pang L, Xu L, Yuan C, Li X, Zhang X, Wang W, Guo X, Ouyang Y, Qiao L, Wang Z, Liu K. Activation of EGFR-KLF4 positive feedback loop results in acquired resistance to sorafenib in hepatocellular carcinoma. Mol Carcinog. 2019 Nov;58(11):2118-2126. doi: 10.1002/mc.23102. Epub 2019 Aug 29. PMID: 31465134.

12. Xu P, Yao J, Ji J, Shi H, Jiao Y, Hao S, Chen D, Shi H. Deficiency of apoptosis-stimulating protein 2 of p53 protects mice from acute hepatic injury induced by CCl4 via autophagy. Toxicol Lett. 2019 Nov;316:85-93. doi: 10.1016/j.toxlet.2019.09.006. Epub 2019 Sep 9. PMID: 31513885.

13. Yao J, Zhou X, Yuan L, Niu LY, Zhang A, Shi H, Duan Z, Xu J. Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites. Clin Nutr. 2020 Jun;39(6):1908-1913. doi: 10.1016/j.clnu.2019.08.006. Epub 2019 Aug 15. PMID: 31472986.

14. Wu M, Liu Z, Zhang A, Li N. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis. Medicine (Baltimore). 2019 Feb;98(5):e14287. doi: 10.1097/MD.0000000000014287. PMID: 30702595; PMCID: PMC6380748.

15. Hou Y, Zhang Y, Qin L, Zhang C, Wang S, Chen D, Li A, Lou J, Yu Y, Dong T, Li N, Zhao Y. Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma. Medicine (Baltimore). 2019 Jan;98(2):e13996. doi: 10.1097/MD.0000000000013996. PMID: 30633185; PMCID: PMC6336587.

16. Zhang H, Qin L, Li C, Jiang J, Sun L, Zhao X, Li N. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy combined with ganciclovir induces hepatoma cell apoptosis. Exp Ther Med. 2019 Mar;17(3):1649-1655. doi: 10.3892/etm.2019.7147. Epub 2019 Jan 2. PMID: 30783433; PMCID: PMC6364201.

17. Wang TZ, Lin DD, Jin BX, Sun XY, Li N. Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging. Exp Ther Med. 2019 Mar;17(3):1919-1929. doi: 10.3892/etm.2018.7117. Epub 2018 Dec 19. PMID: 30783469; PMCID: PMC6364194.

18. Wu M, Liu Z, Zhang A, Li N. Associated measurement of fucosylated levels of AFP, DCP, and GPC3 for early diagnosis in hepatocellular carcinoma. Int J Biol Markers. 2019 Mar;34(1):20-26. doi: 10.1177/1724600818812472. Epub 2019 Mar 10. PMID: 30854929.

19. Wu M, Liu Z, Li X, Zhang A, Lin D, Li N. Analysis of potential key genes in very early hepatocellular carcinoma. World J Surg Oncol. 2019 May 1;17(1):77. doi: 10.1186/s12957-019-1616-6. PMID: 31043166; PMCID: PMC6495517.

20. Meng J, Zhang JG, Du ST, Li N. The effect of gene therapy on postoperative recurrence of small hepatocellular carcinoma (less than 5cm). Cancer Gene Ther. 2019 Mar;26(3-4):114-117. doi: 10.1038/s41417-018-0043-0. Epub 2018 Sep 7. PMID: 30190512.

21. Wu JS, Feng JL, Zhu RD, Liu SG, Zhao DW, Li N. Histopathological characteristics of needle core biopsy and surgical specimens from patients with solitary hepatocellular carcinoma or intrahepatic cholangiocarcinoma. World J Gastrointest Oncol. 2019 May 15;11(5):404-415. doi: 10.4251/wjgo.v11.i5.404. PMID: 31139310; PMCID: PMC6522762.

22. Li J, Qiyu S, Wang T, Jin B, Li N. Improving the Detection of Hepatocellular Carcinoma Using Serum AFP Expression in Combination with GPC3 and Micro-RNA MiR-122 Expression. Open Life Sci. 2019 Mar 20;14:53-61. doi: 10.1515/biol-2019-0007. PMID: 33817137; PMCID: PMC7874791.

23. Wei F, Guo L, Xu Y, Chen D, Gong M. Comparative Pharmacokinetic Study of Taxifolin after Oral Administration of Fructus Polygoni Orientalis Extract in Normal and Fibrotic Rats by UPLC-MS/MS. Evid Based Complement Alternat Med. 2019 Dec 31;2019:9348075. doi: 10.1155/2019/9348075. PMID: 31976002; PMCID: PMC6955125.

24. 田原,任鋒. 乙型肝炎病毒共價閉合環(huán)狀DNA(cccDNA)檢測和清除的研究進(jìn)展[J]. 中華微生物學(xué)和免疫學(xué)雜志,2019,39(11):875-879. DOI:10.3760/cma.j.issn.0254-5101.2019.11.011.

25. 王慧娟,徐玲,田原,等. 內(nèi)質(zhì)網(wǎng)應(yīng)激在乙型重型肝炎(肝衰竭)中的作用研究[J]. 中華肝臟病雜志,2019,27(4):244-249. DOI:10.3760/cma.j.issn.l007-3418.2019.04.002.

26. 張向穎,李紅艷,任鋒,等. 清腸利肝方對急性肝衰竭小鼠肝細(xì)胞凋亡的影響[J]. 中西醫(yī)結(jié)合肝病雜志,2019,29(2):171-173. DOI:10.3969/j.issn.1005-0264.2019.02.023.

27. 張向穎,李紅艷,任鋒,等. 中藥清腸利肝方對肝細(xì)胞自噬的影響及其對小鼠急性肝損傷的保護(hù)作用研究[J]. 北京中醫(yī)藥,2019,38(3):220-223,封3. DOI:10.16025/j.1674-1307.2019.03.006.

28. 郭樂樂,張曉慧,張向穎,胡中杰,任鋒,張晶.對乙酰氨基酚誘導(dǎo)的急性肝損傷小鼠肝組織糖基轉(zhuǎn)移酶Colgalt2表達(dá)的變化[J].實用肝臟病雜志,2019,22(01):29-32.

29. 歐陽雅博,王琛,張岱,等. HIV-1中樞特征性突變的中和敏感性和免疫逃逸分析[J]. 國際病毒學(xué)雜志,2019,26(4):272-276. DOI:10.3760/cma.j.issn.1673-4092.2019.04.016.

30. 孫斌,楊曉珍,謝放,等. 索拉非尼聯(lián)合經(jīng)肝動脈化療栓塞術(shù)和射頻消融對肝細(xì)胞癌患者生存期的影響[J]. 臨床肝膽病雜志,2019,35(1):104-108. DOI:10.3969/j.issn.1001-5256.2019.01.019.

31. 王延軍.“考研評合一”:促進(jìn)教師基本素質(zhì)提升[J].現(xiàn)代教育,2019,(04):7-9.

32. 魏飛力, 柴夢音, 寇卜心, 歐陽雅博, 劉曉霓, 陳德喜. 采用PDX模型探討索拉非尼治療肝細(xì)胞癌早期應(yīng)答基因改變的研究[J]. 北京醫(yī)學(xué), 2019, 41 (06): 464-467.

33. 王爽, 許堅吉, 劉曉霓, 陳德喜. 熒光素酶生物發(fā)光報告體系的優(yōu)化及在肝癌荷瘤裸鼠模型中的應(yīng)用[J]. 實用肝臟病雜志, 2019, 22 (04): 482-485.

34. 張洪海, 孫玉, 劉芳, 謝立, 喬錄新, 陳德喜, 殷繼明. 肝細(xì)胞癌患者血漿基質(zhì)金屬蛋白酶的檢測及臨床意義[J]. 臨床肝膽病雜志, 2019, 35 (04): 825-829.

35. 吳敏, 陳俊梅, 劉召波, 劉海東, 劉超, 張愛英, 李寧. 乙型肝炎病毒核心抗體IgM的蛋白芯片檢測法研究[J]. 現(xiàn)代生物醫(yī)學(xué)進(jìn)展, 2019, 19 (03): 560-562+575.

36. 張向穎,任鋒.內(nèi)質(zhì)網(wǎng)應(yīng)激在肝衰竭發(fā)病機(jī)制中的作用[J].臨床肝膽病雜志,2019,35(09):1920-1923.

37. 林明華,郭向華,喬錄新,等. P53凋亡刺激蛋白2過表達(dá)對轉(zhuǎn)化生長因子β1誘導(dǎo)的肝星狀細(xì)胞活化,、凋亡的影響及其機(jī)制[J]. 中華肝臟病雜志,2019,27(11):890-895. DOI:10.3760/cma.j.issn.1007-3418.2019.11.013.

38. 孫玉,張洪海,陳德喜,等. HBsAg+/HBsAb+慢性乙型肝炎患者S區(qū)基因突變分析[J]. 中國醫(yī)藥導(dǎo)報,2019,16(5):118-121.

39. 王陽, 楊通旺, 吳靜, 高玉雪, 陳德喜, 石英. P53凋亡刺激蛋白2對自噬及其功能調(diào)節(jié)作用機(jī)制的研究進(jìn)展[J]. 北京醫(yī)學(xué), 2019, 41 (10): 923-925.